Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IANB vs Combined IANB and Buccal Infiltration for Irreversible Pulpitis
NCT06276842Phase 2Completed
- Sponsor
- CIMS Dental College
- Start
- Apr 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lidocaine in irreversible pulpitis, sponsored by CIMS Dental College. Started Apr 2020; status: completed.
02
Drugs
lidocaine
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT06276842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06276842.